Open Accessibility Menu

Monoclonal Antibody Clinic

A Treatment Option for COVID-19.

What Are Monoclonal Antibodies?

Monoclonal antibodies are among the most promising treatments for mild to moderate COVID-19. Monoclonal antibodies are just like your body's antibodies but selected for their strong ability to resist the virus. They are produced like a medication and help your body fight illness. In 2020, the Food and Drug Administration issued an emergency use authorization to permit monoclonal antibodies as a treatment option for COVID-19.

How Do Monoclonal Antibodies Treat COVID-19?

After entering your body, monoclonal antibodies look for and attach to the spike protein that sticks out of the coronavirus that causes COVID-19. When monoclonal antibodies attach to the spike protein, they can block the virus's ability to enter cells — and slow down the infection. In 2020, the FDA authorized several different monoclonal antibodies to treat COVID-19.

Who is eligible for monoclonal antibody treatment?

Anyone who tested positive for COVID-19 and has had mild to moderate symptoms for seven days or less qualifies for this treatment.

How to find out if you qualify and to receive monoclonal antibodies treatment?

Potential patients can find out if they qualify by speaking directly with their provider and getting a referral for the treatment.

What to Expect During Monoclonal Antibody Treatment

Health care workers administer monoclonal antibodies with a one-time intravenous (IV) infusion. The IV infusion involves placing a needle in a vein and gradually sending the medicine through the IV and into the body.

The infusion takes about an hour. After the IV is removed, patients must wait at least one more hour so health care workers can watch for side effects or negative reactions.